ServiceTitan (TTAN) Instills Confidence Prior to Earnings Release

ServiceTitan Incorporated (NASDAQ:TTAN) is one of the 10 beaten-down technology stocks that could bounce back in 2026.

As of February 26 closing, consensus sentiment for ServiceTitan Incorporated (NASDAQ:TTAN) was strongly bullish. The stock received coverage from 14 analysts, 13 of whom assigned Buy ratings and 1 gave a Hold call. With no Sell rating, it has a projected median 1-year price target of $131.77. This results in an upside potential of more than 82% at the prevailing level.

On February 23, Andrew Sherman of TD Cowen reduced the firm’s price target on ServiceTitan Incorporated (NASDAQ:TTAN) from $160 to $130. The analyst maintained his Buy rating on the shares.

Stock market data on a laptop screen. Photo by Alesia Kozik on Pexels

TD Cowen revised its estimates ahead of the company’s fourth-quarter earnings and anticipates results to exceed the company’s prior growth outlook of 17%. The analyst noted that colder winter conditions could drive higher platform usage and expects fiscal 2027 revenue guidance to come in above current Wall Street projections of 15% growth.

ServiceTitan Incorporated (NASDAQ:TTAN) operates cloud-based software platforms that integrate various business functions, such as advertising, contracting, invoicing, payment processing, reporting, recruitment, and others. It facilitates these functions through ServiceTitan, FieldRoutes, Aspire, and Convex platforms. The company also engages with heating, ventilation, and air conditioning (HVAC) businesses for plumbing, irrigation, water treatment, painting, pest control, roofing, and other relevant solutions.

While we acknowledge the potential of TTAN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 17 Biotechnology Stocks with More Than 50% Upside and 12 Oversold Financial Stocks to Invest in According to Hedge Funds.

Disclosure: None.